Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HKDC1 | Q2TB90 | 2/20 | 0.67 |
| ▸ | IDO1 | P14902 | 1/20 | 0.50 |
| ▸ | CDC25A | P30304 | 1/20 | 0.50 |
| ▸ | CDC25B | P30305 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 14/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.46 |
| ▸ | TDP2 | O95551 | 1/20 | 0.45 |
| ▸ | NSD2 | O96028 | 1/20 | 0.45 |
| ▸ | MPEG1 | Q2M385 | 4/20 | 0.44 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9654553 | 0.83 | HKDC1 (0.67) | HKDC1IDO1CDC25ACDC25BKDM4E | |
| SCHEMBL3413590 | 0.80 | HKDC1 (1.00) | HKDC1IDO1CDC25ACDC25BKDM4E | |
| SCHEMBL31189916 | 0.79 | HKDC1 (0.50) | HKDC1IDO1CDC25ACDC25BKDM4E | |
| SCHEMBL5163654 | 0.77 | HKDC1 (0.69) | HKDC1IDO1CDC25ACDC25BKDM4E | |
| SCHEMBL5983372 | 0.74 | HKDC1 (0.72) | HKDC1IDO1CDC25ACDC25BKDM4E | |
| SCHEMBL23201029 | 0.72 | HKDC1 (0.62) | HKDC1IDO1CDC25ACDC25BKDM4E | |
| SCHEMBL9655259 | 0.72 | ALOX5 (0.55) | ALOX5MPEG1 | |
| SCHEMBL9578874 | 0.71 | ALOX5 (0.70) | ALOX5MPEG1 | |
| SCHEMBL4908282 | 0.71 | MAPT (0.48) | HKDC1IDO1CDC25ACDC25BKDM4E | |
| SCHEMBL9578682 | 0.69 | ALOX5 (0.77) | HKDC1ALOX5MPEG1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090131705-A1 | Practical, Cost-Effective Synthesis of Ubiquinones | ZYMES, LLC | 2009-05-21 | — | — | US | disclosed |
| EP-1968608-A2 | PRACTICAL, COST-EFFECTIVE SYNTHESIS OF UBIQUINONES | Zymes, LLC (US) | 2008-09-17 | — | — | EP | disclosed |
| US-20070260076-A1 | Practical, Cost-Effective Synthesis of Ubiquinones | ZYMES, LLC | 2007-11-08 | — | — | US | disclosed |
| WO-2007078679-A2 | PRACTICAL, COST-EFFECTIVE SYNTHESIS OF UBIQUINONES | ZYMES, LLC (US) | 2007-07-12 | — | — | WO | disclosed |
| EP-1694623-A4 | PRACTICAL, COST-EFFECTIVE SYNTHESIS OF UBIQUINONES | ZYMES INC (US) | 2007-01-17 | — | — | EP | disclosed |
| EP-1694623-A2 | PRACTICAL, COST-EFFECTIVE SYNTHESIS OF UBIQUINONES | Zymes, Inc. (US) | 2006-08-30 | — | — | EP | disclosed |
| US-20060167289-A1 | Practical, cost-effective synthesis of ubiquinones | ZYMES, LLC (US) | 2006-07-27 | — | — | US | disclosed |
| US-20050148675-A1 | Practical, cost-effective synthesis of ubiquinones | ZYMES, INC. (US) | 2005-07-07 | — | — | US | disclosed |
| WO-2005056812-A2 | PRACTICAL, COST-EFFECTIVE SYNTHESIS OF UBIQUINONES | ZYMES, INC. (US) | 2005-06-23 | — | — | WO | disclosed |
| EP-0355492-B1 | REACTIVE DYES | BAYER AG (DE) | 1992-12-09 | — | — | EP | disclosed |
| EP-0141996-B1 | TRIPHENDIOXAZINE REACTIVE DYES | BAYER AG (DE) | 1987-11-25 | — | — | EP | disclosed |
| EP-0229339-A2 | Water soluble triphene dioxazine compounds, their starting compounds containing sulphonyl groups, process for their preparation and use of the triphene dioxazines as dyestuffs | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-07-22 | — | — | EP | disclosed |
| EP-0144580-B1 | TRIPHENDIOXAZINE DYES | BAYER AG (DE) | 1987-07-08 | — | — | EP | disclosed |
| EP-0222098-A2 | Water soluble triphenodioxazine compounds, process for their preparation and their use as dyestuffs | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-05-20 | — | — | EP | disclosed |
| US-4629788-A | COLORFASTNESS; BLUE COLOR; NATURAL AND SYNTHETIC FIBER | BAYER AKTIENGESELLSCHAFT (DE) | 1986-12-16 | — | — | US | disclosed |
| US-4621138-A | Triphendioxazine dyestuffs | BAYER AKTIENGESELLSCHAFT (DE) | 1986-11-04 | — | — | US | disclosed |
| US-4591643-A | Triphendioxazine reactive dyestuffs | BAYER AKTIENGESELLSCHAFT (DE) | 1986-05-27 | — | — | US | disclosed |
| EP-0158882-A2 | Triphenedioxazine dyes | BAYER AG (DE) | 1985-10-23 | — | — | EP | disclosed |
| EP-0144580-A2 | Triphendioxazine dyes | BAYER AG (DE) | 1985-06-19 | — | — | EP | disclosed |
| EP-0141996-A2 | Triphendioxazine reactive dyes | BAYER AG (DE) | 1985-05-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060167289-A1 | Practical, cost-effective synthesis of ubiquinones | SQOR, NDUFS6, NDUFS5 | HKDC1 1395/4885IDO1 1816/4885CDC25A 3959/4885 |
| US-20070260076-A1 | Practical, Cost-Effective Synthesis of Ubiquinones | SQOR, NDUFS6, NDUFS5 | HKDC1 1395/4885IDO1 1816/4885CDC25A 3959/4885 |
| US-20090131705-A1 | Practical, Cost-Effective Synthesis of Ubiquinones | SQOR, NDUFS6, NDUFS5 | HKDC1 1395/4885IDO1 1816/4885CDC25A 3959/4885 |
| US-20050148675-A1 | Practical, cost-effective synthesis of ubiquinones | SQOR, NDUFS6, NDUFS5 | HKDC1 1395/4885IDO1 1816/4885CDC25A 3959/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.